COMMUNIQUÉS West-GlobeNewswire

Ashwagandha Testosterone Boost: Does Ashwagandha Increase Testosterone? Testosil Supplement Review
23/04/2025
Research suggests that ashwagandha can significantly increase testosterone levels in men. Testosil clinically proven ashwagandha extract boosts testosterone more than exercise alone! Las Vegas, April 23, 2025 (GLOBE [...]
Tren Cycle: Trenbolone Steroids Before And After Cycle Results - Legal Tren Steroids For Sale Online from CrazyBulk
23/04/2025
Albany, New York, April 23, 2025 (GLOBE NEWSWIRE) -- Anabolic steroids are carefully formulated chemical substances that serve as important organs in the body. The purpose varies depending on the formulation, with some [...]
Where to Buy Testosterone Online 2025 - Top 3 Best Brands of Testosterone Cypionate (Trusted Sites with Testosterone for Sale) - By Testosil
23/04/2025
Las Vegas, April 23, 2025 (GLOBE NEWSWIRE) -- Testosterone is a powerful hormone that is applied to male reproductive and sexual growth . It is used for muscle mass, strength, and endurance also. But as a man grows [...]
Best Magnesium Supplements for Weight Loss 2025: Benefits, Dosage & Types Explained - by bioptimizers
23/04/2025
Kietzke Lane, April 23, 2025 (GLOBE NEWSWIRE) -- Magnesium is one of the few minerals that the body uses over 300 times a day. Magnesium is charged with energy production and muscle contraction to a normal heartbeat and [...]
Comprehensive Mental Health Care: NJ Chef-Turned-Health Care Provider Blends Medication, Therapy, And Holistic Strategies To Treat Patients
23/04/2025
MindSync Psychiatry, founded by William Chu, PMHNP-BC, delivers evidence-based psychiatric care with a personalized approach across New Jersey BASKING RIDGE, N.J., April 23, 2025 (GLOBE NEWSWIRE) -- For the past two [...]
Science Translational Medicine Study Funded by the Bay Area Lyme Foundation Identifies FDA-approved Piperacillin as More Effective, Targeted Treatment for Lyme Disease
23/04/2025
An additional Science Translational Medicine study also funded by Bay Area Lyme Foundation uncovers how lingering bacterial cell wall molecules may contribute to chronic Lyme symptoms PORTOLA VALLEY, Calif., April 23, [...]
SynoGut Reviews (ALERT) Consumer Reports Reveal Unexpected Truths Behind Its Ingredients And Side Effects
23/04/2025
CANTON, Ohio, April 23, 2025 (GLOBE NEWSWIRE) -- SynoGut is a gut health support supplement that provides a natural way to support a healthy digestive system. The dietary formula is a combination of natural herbs, [...]
Pineal XT Reviews (WARNING) Is It Safe And Worth Trying? Understanding Its Natural Ingredients And Benefits!
23/04/2025
ALBANY, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Pineal XT is a natural dietary capsule developed and designed to support cognitive functions. It blends in scientifically proven ingredients to enhance brain power, [...]
Prime Biome Reviews (We Tried It for 115 Days) Here’s Our Month-by-Month Review, Unexpected Results, And Benefits!
23/04/2025
ALBANY, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- Prime Biome is a dietary supplement designed to support skin and gut health by achieving microbial equilibrium in the body. It is loaded with probiotics for clear skin [...]
John Flack Appointed CFO of Advanced Medical Pricing Solutions
23/04/2025
PHOENIX, April 23, 2025 (GLOBE NEWSWIRE) -- Advanced Medical Pricing Solutions (“AMPS”), a diversified healthcare technology company supporting transparent, affordable medical and prescription benefits, announced today [...]
AB Science announces that EMA granted orphan drug status to AB8939 for the treatment of acute myeloid leukemia
23/04/2025
PRESS RELEASE EUROPEAN MEDICINES AGENCY (EMA) HAS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR AB8939 IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA Paris, April 23, 2025, 6.45pm CET AB Science SA (Euronext - [...]
La molécule AB8939 obtient la désignation de médicament orphelin auprès de l'EMA dans le traitement de la leucémie myéloïde aigue
23/04/2025
COMMUNIQUE DE PRESSE LA MOLECULE AB8939 OBTIENT LA DESIGNATION DE MEDICAMENT ORPHELIN DANS L’UNION EUROPEENNE AUPRES DE L’AGENCE EUROPEENNE DES MEDICAMENTS (EMA) DANS LE TRAITEMENT DE LA LEUCEMIE MYELOÏDE AIGUE Paris, [...]
Artax Biopharma to present Phase 2a data on Nck modulator AX-158, establishing novel mechanism of action in autoimmune disease at the 2025 SID Annual Meeting
23/04/2025
Late breaker abstract presentation to showcase clinical validation of first-in-class oral small molecule AX-158 in cohort of patients with psoriasis Full dataset to expand on previously announced topline results, [...]
EssilorLuxottica: Q1 2025 Revenue - Strong revenue growth in the first quarter
23/04/2025
Strong revenue growth in the first quarter Group’s revenue up 8.1% at current and 7.3% at constant exchange rates 1 in Q1 Sound growth in both PS and DTC channels, with comparable-store sales 3 up 8% EMEA growing 10% at [...]
EssilorLuxottica: Chiffre d’affaires T1 2025 - Forte croissance du chiffre d'affaires au premier trimestre
23/04/2025
Forte croissance du chiffre d'affaires au premier trimestre Chiffre d'affaires du Groupe en hausse de +8,1 % à taux de change courants et de +7,3 % à taux de change constants 1 au T1 Solide croissance des segments [...]
OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025
23/04/2025
OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025 Featuring proprietary asset Tedopi® and two partnered SIRPα inhibitor assets with Boehringer Ingelheim NANTES, France – April 23, 2025, [...]
OSE Immunotherapeutics annonce la sélection de plusieurs abstracts pour présentation à l’ASCO 2025
23/04/2025
OSE Immunotherapeutics annonce la sélection de plusieurs abstracts pour présentation à l’ASCO 2025 Présentations sur l’actif propriétaire Tedopi® et sur deux inhibiteurs de SIRPα développés en partenariat avec [...]
Arvinas Announces Results from the VERITAC-2 Trial Selected as Late-Breaking Oral Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
23/04/2025
– Oral presentation will serve as first presentation of detailed results from the Phase 3 VERITAC-2 clinical trial – NEW HAVEN, Conn., April 23, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that [...]
ImCheck Announces Oral Presentation of Updated ICT01 Efficacy Data in First-line AML at the ASCO Annual Meeting 2025
23/04/2025
ImCheck Announces Oral Presentation of Updated ICT01 Efficacy Data in First-line AML at the ASCO Annual Meeting 2025 Marseille, France, April 23, 2025 10:00 a.m. ET / 4:00 p.m. CET– ImCheck Therapeutics announced today [...]

Pages